Weeks Two Through Four: Peak Adjustment Period The second through fourth weeks represent the most challenging adaptation window for many patients, as side effects may intensify before gradually resolving
Mounjaro (tirzepatide) Manufacturer: Eli Lilly and Company What It Is : Mounjaro is a newer medication combining GLP-1 and GIP (Glucose-dependent Insulinotropic Polypeptide) receptor agonist properties
If you cannot tolerate the maintenance dose of 2.4 mg, your doctor may keep you on 1.7 mg once weekly
After eating, carbohydrates from food are converted into glucose, which raises blood sugar levels
It is not known if Wegovy will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people
Claims concerning detoxification, neurological disease, liver repair, immune treatment, skin pigmentation or disease prevention may contribute to medicinal classification